GET HELP NOW

Tuesday, November 28, 2017

Molecular profiling of melanoma tumors explains differences in survival after T cell therapy

http://ift.tt/eA8V8J The more times metastasized melanoma has mutated and the patient’s immune system has been activated against the tumor – the better the chances of survival after immunotherapy.

from http://ift.tt/2AhQgZC
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Children whose mothers use marijuana are more likely to try it at younger age

When mothers use marijuana during the first 12 years of their child's life, their cannabis-using children are more likely to start at an...